logo
Plus   Neg
Share
Email

Kohl's Slashes FY19 Adj. EPS Guidance - Quick Facts

While reporting financial results for the first quarter on Monday, retailer Kohl's Corp. (KSS) slashed its adjusted earnings guidance for the full-year 2019. For the first quarter, the company reported that comparable sales decreased 3.4 percent.

For fiscal 2019, the company slashed its adjusted earnings guidance to a range of $5.15 to $5.45 per share from the prior guidance range of $5.80 to $6.15 per share.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $6.04 per share for the year. Analysts' estimates typically exclude special items.

Last week, Kohl's Board of Directors declared a quarterly cash dividend on the Company's common stock of $0.67 per share, payable June 26, 2019 to shareholders of record at the close of business on June 12, 2019.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
eBay Inc. (EBAY) Wednesday reported a fourth-quarter profit that trumped Wall Street analysts' estimates, as did revenues. However, shares of the company slipped over 5% after the company issued a weak outlook for the first quarter. eBay's fourth-quarter profit dropped to $558 million or $0.69 per... Apple Inc. (AAPL) Wednesday reported a first-quarter profit that trumped Wall Street estimates, as the iPhone maker reported its "highest quarterly revenue ever" driven by strong demand for its iPhone 11 and 11 Pro models during the holiday season. The tech giant also issued a strong revenue outlook... New York Attorney General Letitia James has fled a lawsuit against Vyera Pharmaceuticals and two of its former CEOs, including imprisoned 'Pharma Bro' Martin Shkreli, for illegally monopolizing a life-saving drug Daraprim. The lawsuit seeks a lifetime ban on Shkreli and his business partner Kevin Mulleady working in the pharmaceutical industry.
Follow RTT
>